.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Cantor Fitzgerald
Chinese Patent Office
Daiichi Sankyo
Express Scripts
McKinsey
Chubb
Cipla
Novartis
Fuji

Generated: November 21, 2017

DrugPatentWatch Database Preview

Dr Reddys La Company Profile

« Back to Dashboard

What is the competitive landscape for DR REDDYS LA, and when can generic versions of DR REDDYS LA drugs launch?

DR REDDYS LA has one hundred and seventy-seven approved drugs.

There are five US patents protecting DR REDDYS LA drugs on DR REDDYS LA drugs in the past three years. There are eleven tentative approvals on DR REDDYS LA drugs.

There are ninety-three patent family members on DR REDDYS LA drugs in forty-eight countries and two hundred and thirty-five supplementary protection certificates in thirteen countries.

Summary for Dr Reddys La

International Patents:93
US Patents:5
Tradenames:139
Ingredients:123
NDAs:177
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Inc
NEFAZODONE HYDROCHLORIDE
nefazodone hydrochloride
TABLET;ORAL076309-005Sep 16, 2003BXRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
IRBESARTAN AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; irbesartan
TABLET;ORAL203500-001Sep 27, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
SERTRALINE HYDROCHLORIDE
sertraline hydrochloride
TABLET;ORAL076442-001Apr 30, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
RISPERIDONE
risperidone
TABLET;ORAL076879-004Oct 24, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Sa
HABITROL
nicotine
FILM, EXTENDED RELEASE;TRANSDERMAL020076-004Nov 12, 1999OTCYesNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
MONTELUKAST SODIUM
montelukast sodium
TABLET;ORAL201582-001Aug 6, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
FAMOTIDINE
famotidine
TABLET;ORAL075718-001Apr 16, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
MOXIFLOXACIN HYDROCHLORIDE
moxifloxacin hydrochloride
TABLET;ORAL076938-001Mar 4, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Inc
NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE
naproxen sodium; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL077381-001Sep 27, 2006OTCNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
OMEPRAZOLE
omeprazole
CAPSULE, DELAYED REL PELLETS;ORAL078490-001Apr 17, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Dr Reddys La

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dr Reddys Labs Sa
HABITROL
nicotine
FILM, EXTENDED RELEASE;TRANSDERMAL020076-004Nov 12, 1999► Subscribe► Subscribe
Dr Reddys Labs Sa
HABITROL
nicotine
FILM, EXTENDED RELEASE;TRANSDERMAL020076-005Nov 12, 1999► Subscribe► Subscribe
Dr Reddys Labs Sa
HABITROL
nicotine
FILM, EXTENDED RELEASE;TRANSDERMAL020076-005Nov 12, 1999► Subscribe► Subscribe
Dr Reddys Labs Sa
HABITROL
nicotine
FILM, EXTENDED RELEASE;TRANSDERMAL020076-006Nov 12, 1999► Subscribe► Subscribe
Dr Reddys Labs Sa
HABITROL
nicotine
FILM, EXTENDED RELEASE;TRANSDERMAL020076-006Nov 12, 1999► Subscribe► Subscribe
Dr Reddys Labs Sa
HABITROL
nicotine
FILM, EXTENDED RELEASE;TRANSDERMAL020076-006Nov 12, 1999► Subscribe► Subscribe
Dr Reddys Labs Sa
HABITROL
nicotine
FILM, EXTENDED RELEASE;TRANSDERMAL020076-005Nov 12, 1999► Subscribe► Subscribe
Dr Reddys Labs Sa
HABITROL
nicotine
FILM, EXTENDED RELEASE;TRANSDERMAL020076-004Nov 12, 1999► Subscribe► Subscribe
Dr Reddys Labs Sa
HABITROL
nicotine
FILM, EXTENDED RELEASE;TRANSDERMAL020076-004Nov 12, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for DR REDDYS LA drugs

Drugname Dosage Strength Tradename Submissiondate
omeprazole
Delayed-release Tablets20 mg
OMEPRAZOLE
6/3/2015
amoxicillin and clavulanate potassium
Extended-release Tablets1000 mg/62.5 mg
AUGMENTIN XR
1/21/2009

Non-Orange Book Patents for Dr Reddys La

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,294,199 Method of treating a bacterial infection comprising administering amoxycillin► Subscribe
6,660,299 Modified release pharmaceutical formulation comprising amoxycillin► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Dr Reddys La Drugs

Country Document Number Estimated Expiration
China1225246► Subscribe
World Intellectual Property Organization (WIPO)0061115► Subscribe
New Zealand514574► Subscribe
Sweden0001330► Subscribe
Ireland20000271► Subscribe
Israel145581► Subscribe
Hungary0001471► Subscribe
Uruguay26104► Subscribe
Denmark200000602► Subscribe
United Kingdom2365337► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Dr Reddys La Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0031Belgium► SubscribePRODUCT NAME: MYCOPHENOLATE MOFETIL; NAT. REGISTRATION NO/DATE: EU/1/96/005/001 19960214; FIRST REGISTRATION: CH 53337 19951103
496Luxembourg► SubscribePRODUCT NAME: COMBINAISON DE DAPAGLIFLOZINE OU D UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DE METFORMINE OU D UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI,TELLE QUE PROTEGEE PAR LE BREVET DE BASE EP1506211 B1
745Luxembourg► SubscribePRODUCT NAME: NETUPITANT/PALONOSETRON ET LEURS DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (AKYNZEO); FIRST REGISTRATION: 20150527
C/GB02/027United Kingdom► SubscribePRODUCT NAME: 2-(2-AMINO-1,6-DIHYDRO-6-OXO-PURIN-9-YL)-METHOXY-3-HYDROXY-1-PROPANYL-L-VALINATE HYDROCHLORIDE (VALGANCICLOVIR HYDROCHLORIDE); REGISTERED: NL RVG 25992 20010920; UK PL 00031/0599 20020425
C/GB11/013United Kingdom► SubscribePRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105
C0023France► SubscribePRODUCT NAME: ANASTROZOLE, EVENTUELLEMENT SOUS LA FORME D UN SEL D ADDITION ACCEPTABLE EN MEDECINE PHARMACEUTIQUE; NAT REG. NO/DATE: NL 21126 19961227; FIRST REG.: 12619/0106 19950811
70017Netherlands► SubscribePRODUCT NAME: TOPOTECAN, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARD BAAR ZOUT, HYDRAAT OF SOLVAAT, IN HET BIJZONDER HET HYDROCHLORI DE; NAT. REGISTRATION NO/DATE: EU/1/96/027/001 - EU/1/96/027/002 19961112; FIRST REGISTRATION: CH IKS 53857 19961016
1998Austria► SubscribePRODUCT NAME: DONEPEZIL UND SEINE PHARMAKOLOGISCH ANNEHMBAREN SALZE, INSBESONDERE DONEPEZIL HYDROCHLORID; NAT. REGISTRATION NO/DATE: 1-22056, 1-22057 19970728; FIRST REGISTRATION: GB PL105550006, PL105550007 19970214
C0128France► SubscribePRODUCT NAME: LATANOPROST; REGISTRATION NO/DATE IN FRANCE: NL 22549 DU 19970724; REGISTRATION NO/DATE AT EEC: 12716 DU 19960718
C0046Belgium► SubscribePRODUCT NAME: DOXORUBICIN HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/96/011/001 19960624
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Cipla
Dow
Express Scripts
US Army
Teva
Queensland Health
Novartis
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot